ClinConnect ClinConnect Logo
Search / Trial NCT06422312

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

Launched by GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD. · May 15, 2024

Trial Information

Current as of May 19, 2025

Withdrawn

Keywords

Cystoscopy

ClinConnect Summary

This randomized study will compare the cumulative procedure time between cystoscopy performed with the Redpine® Rflex endo(trademark) High-Definition Cystoscope and the site's standard of care reusable flexible cystoscope in adult study participants requiring cystoscopy for visualization of and/or intervention on the urinary bladder. The study will evaluate the user experience and product performance during cystoscopic procedures. Participant experience, tolerance to the procedure, and any differences in adverse events between disposable and reusable scope will be evaluated. The hypothesis ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male or female, aged at least 18 years old
  • 2. Patient undergoing routine flexible cystoscopy
  • 3. No active urinary tract infection
  • 4. Subject is willing and able to sign informed consent and HIPAA authorization.
  • Exclusion Criteria:
  • 1. Known unpassable urethral stricture
  • 2. Febrile patient with active urinary tract infection (UTI)
  • 3. Subjects with acute infection (acute urethritis, acute prostatitis, acute epididymitis)
  • 4. Subject with severe coagulopathy
  • 5. Subject is pregnant or female with reproductive capability who is unwilling to have a pre-procedure pregnancy test and use birth control.

About Guangzhou Red Pine Medical Instrument Co., Ltd.

Guangzhou Red Pine Medical Instrument Co., Ltd. is a leading medical device manufacturer specializing in the development and production of innovative healthcare solutions. With a commitment to enhancing patient outcomes and advancing medical technologies, the company focuses on high-quality instrumentation for various clinical applications. Leveraging state-of-the-art manufacturing processes and rigorous quality control measures, Guangzhou Red Pine aims to meet international standards and regulatory requirements. Through strategic partnerships and a dedication to research and development, the company actively contributes to the global healthcare landscape, fostering advancements that improve diagnostic accuracy and treatment efficacy.

Locations

Seattle, Washington, United States

Dallas, Texas, United States

Hershey, Pennsylvania, United States

Hersey, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Yair Lotan, MD

Principal Investigator

UT Southwestern Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported